Retired NBME Answer Explanations

Second Aid\immunology

\lymphoid structures\Lymph node
\lymphoid structures\Lymph drainage
\lymphoid structures\Sinusoids of spleen
\lymphoid structures\Thymus
\cellular components\Innate vs. adaptive immunity
\cellular components\MHC I and II
\cellular components\HLA subtypes associated with diseases
\cellular components\Natural killer cells
\cellular components\Major functions of B and T cells
\cellular components\Differentiation of T cells
\cellular components\T- and B-cell activation
\cellular components\Helper T cells
\cellular components\Cytotoxic T cells
\cellular components\Regulatory T cells
\immune responses\Antibody structure and function
\immune responses\Immunoglobulin isotypes
\immune responses\Antigen type and memory
\immune responses\Complement
\immune responses\Complement deficiencies
\immune responses\Important cytokines
\immune responses\Interferon mechanism
\immune responses\Cell surface proteins
\immune responses\Anergy
\immune responses\Effects of bacterial toxins
\immune responses\Antigen variation
\immune responses\Passive vs. active immunity
\immune responses\Vaccinantion
\immune responses\Hypersensitivity
\immune responses\Hypersensitivity disorders
\immune responses\Blood transfusion reactions
\immune responses\Autoantibodies
\immune responses\Infections in immunodeficiency
\immune responses\Immune deficiencies
\immune responses\Immune deficiencies (continued)
\immune responses\Grafts
\immune responses\Transplant rejection
\immunosuppressants\Cyclosporine
\immunosuppressants\Tacrolimus (FK506)
\immunosuppressants\Sirolimus (rapamycin)
\immunosuppressants\Daclizumab
\immunosuppressants\Azathioprine
\immunosuppressants\Muromonab CD3 (OKT3)
\immunosuppressants\Recombinant cytokines and clinical uses
\immunosuppressants\Therapeutic antibodies